At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ZYME ZYMEWORKS INC (US)
Closed 02-11 16:00:00 EST
22.83
+0.10
+0.44%
盘后22.87
+0.04+0.18%
17:39 EST
High22.90Low22.07Vol680.98K
Open22.65D1 Closing22.73Amplitude3.65%
Mkt Cap1.71BTradable Cap874.38MTotal Shares74.84M
T/O15.38MT/O Rate1.78%Tradable Shares38.30M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Zymeworks Inc. Files Initial Statement of Beneficial Ownership for SVP & Chief Medical Officer Sabeen Mekan
Reuters  ·  02-03
Zymeworks Inc. Files Initial Statement of Beneficial Ownership for SVP & Chief Medical Officer Sabeen Mekan
Zymeworks Inc. Joins Leerink Global Healthcare Conference for Fireside Chat
Reuters  ·  01-27
Zymeworks Inc. Joins Leerink Global Healthcare Conference for Fireside Chat
Assessing Zymeworks (ZYME) Valuation After Major Leadership And Board Reshuffle
Simply Wall St.  ·  01-27
Assessing Zymeworks (ZYME) Valuation After Major Leadership And Board Reshuffle
Zymeworks Inc. unveils strategy focused on growing royalty portfolio and advancing novel medicines for difficult-to-treat diseases
Reuters  ·  01-21
Zymeworks Inc. unveils strategy focused on growing royalty portfolio and advancing novel medicines for difficult-to-treat diseases
Zymeworks Inc. Files Initial Beneficial Ownership Statement for Mark Hollywood, EVP & Chief Operating Officer
Reuters  ·  01-14
Zymeworks Inc. Files Initial Beneficial Ownership Statement for Mark Hollywood, EVP & Chief Operating Officer
Zymeworks Inc. Files Initial Statement of Beneficial Ownership for Director Brian N. Cherry
Reuters  ·  01-14
Zymeworks Inc. Files Initial Statement of Beneficial Ownership for Director Brian N. Cherry
BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
Reuters  ·  01-12
BUZZ-U.S. STOCKS ON THE MOVE-AbCellera Biologics, Zymeworks, Silver miners
Zymeworks Chief Finance, Medical, Scientific Officers Leaving in Executive Reorg
Dow Jones  ·  01-12
Zymeworks Chief Finance, Medical, Scientific Officers Leaving in Executive Reorg
Zymeworks Inc. unveils pipeline progress and partnership milestones in latest corporate presentation
Reuters  ·  01-12
Zymeworks Inc. unveils pipeline progress and partnership milestones in latest corporate presentation
Zymeworks Inc. Appoints New Executives and Board Member
Reuters  ·  01-12
Zymeworks Inc. Appoints New Executives and Board Member
Zymeworks Inc - Leone Patterson Will Depart From CFO Role During Q1 2026
THOMSON REUTERS  ·  01-12
Zymeworks Inc - Leone Patterson Will Depart From CFO Role During Q1 2026
Zymeworks Inc - Galbraith Assumes Role of Acting CFO
THOMSON REUTERS  ·  01-12
Zymeworks Inc - Galbraith Assumes Role of Acting CFO
Press Release: Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
Dow Jones  ·  01-12
Press Release: Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
Zymeworks outlines priorities, outlook for 2026
TIPRANKS  ·  01-12
Zymeworks outlines priorities, outlook for 2026
Zymeworks Inc. Outlines Strategy to Drive Long-Term Value Through Royalty Growth, Strategic Acquisitions, and Internal R&D Innovation Supported by Strengthened Financial Foundation
Reuters  ·  01-12
Zymeworks Inc. Outlines Strategy to Drive Long-Term Value Through Royalty Growth, Strategic Acquisitions, and Internal R&D Innovation Supported by Strengthened Financial Foundation
BRIEF-Zymeworks Outlines Strategic Priorities And Outlook For 2026
Reuters  ·  01-12
BRIEF-Zymeworks Outlines Strategic Priorities And Outlook For 2026
Zymeworks Outlines Strategic Priorities and Outlook for 2026
THOMSON REUTERS  ·  01-12
Zymeworks Outlines Strategic Priorities and Outlook for 2026
Zymeworks Inc: Global Phase 1 Clinical Trial Investigating ZW191 in Solid Tumors Is Ongoing With Dose Optimization of ZW191 in Ovarian Cancer
THOMSON REUTERS  ·  01-12
Zymeworks Inc: Global Phase 1 Clinical Trial Investigating ZW191 in Solid Tumors Is Ongoing With Dose Optimization of ZW191 in Ovarian Cancer
Zymeworks: up to $440 Mln in Milestone Payments Eligible to Be Earned Related to Regulatory Approvals of Ziihera in Gea in United States, Europe, Japan, & China
THOMSON REUTERS  ·  01-12
Zymeworks: up to $440 Mln in Milestone Payments Eligible to Be Earned Related to Regulatory Approvals of Ziihera in Gea in United States, Europe, Japan, & China
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Pacira Pharmaceuticals (PCRX) and Beta Bionics, Inc. (BBNX)
TIPRANKS  ·  01-09
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Pacira Pharmaceuticals (PCRX) and Beta Bionics, Inc. (BBNX)

Introduction

Company Name.
ZYMEWORKS INC (US)
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--